Sarcopenia is associated with cardiovascular risk in patients with COPD, independent of adiposity
J. Jung (Seoul, Republic of Korea), A. Leem (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), K. Chung (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea)
Source: International Congress 2022 – COPD: from biomarkers to phenotypes and severity
Session: COPD: from biomarkers to phenotypes and severity
Session type: Thematic Poster
Number: 3883
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Jung (Seoul, Republic of Korea), A. Leem (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), K. Chung (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea). Sarcopenia is associated with cardiovascular risk in patients with COPD, independent of adiposity. 3883
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|